Sichuan Bojia Pharmaceutical Co., Ltd. (medical raw materials) is located in the eastern zone of the Meishan Economic Development Zone, Sichuan, and is a pharmaceutical enterprise engaged in the production of active pharmaceutical ingredients and the supply of medical raw materials, holding drug production licence Chuan 20160042. Its core products are hydroxyethyl starch 130/0.4, icodextrin and iron sucrose, and its approved raw-material drug range also covers fasudil hydrochloride, hydroxyethyl starch 200/0.5, calcitriol, dutasteride and parecoxib sodium. The company's website presents a corporate profile, a GMP certification page and a drug catalogue in which the featured medicines hydroxyethyl starch 130/0.4 and fasudil hydrochloride carry national drug approval numbers H20060873 and H20123451 respectively, with 1 qualification certificate published. Official website: https://scbjzyyxgs.yaopinku.com.cn/ Sichuan Bojia Pharmaceutical Co., Ltd. (medical raw materials) is located in the eastern zone of the Meishan Economic Development Zone, Sichuan, and is a pharmaceutical enterprise engaged in the production of active pharmaceutical ingredients and the supply of medical raw materials, holding drug production licence Chuan 20160042. Its core products are medical raw materials including icodextrin and iron sucrose as well as hydroxyethyl starch, while the approved range also covers fasudil hydrochloride, hydroxyethyl starch 200/0.5, calcitriol, dutasteride, parecoxib sodium and other raw-material drugs supplied to downstream pharmaceutical manufacturers. The company's website presents a corporate profile, a GMP certification page and a drug catalogue in which the featured medicines hydroxyethyl starch 130/0.4 and fasudil hydrochloride carry national drug approval numbers H20060873 and H20123451 respectively, with 1 qualification certificate published. Official website: https://scbjzyyxgs.yaopinku.com.cn/